All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: HIV Infections-28750025
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 28750025 A71AT
PR
gag-pol
HIV Infections
D
G
R
C
L
View
2 28750025 A71AV
PR
gag-pol
HIV Infections
D
G
R
C
L
View
3 28750025 A71T
PR
gag-pol
HIV Infections
D
G
R
C
L
View
4 28750025 D67N
RT
gag-pol
HIV Infections
D
G
R
C
L
View
5 28750025 F116FI
RT
gag-pol
HIV Infections
D
G
R
C
L
View
6 28750025 F116FY
RT
gag-pol
HIV Infections
D
G
R
C
L
View
7 28750025 G190A
RT
gag-pol
HIV Infections
D
G
R
C
L
View
8 28750025 H221Y
RT
gag-pol
HIV Infections
D
G
R
C
L
View
9 28750025 I54V
PR
gag-pol
HIV Infections
D
G
R
C
L
View
10 28750025 K101E
RT
gag-pol
HIV Infections
D
G
R
C
L
View
11 28750025 K103N
RT
gag-pol
HIV Infections
D
G
R
C
L
View
12 28750025 K70K
RT
gag-pol
HIV Infections
D
G
R
C
L
View
13 28750025 K70R
RT
gag-pol
HIV Infections
D
G
R
C
L
View
14 28750025 L10I
PR
gag-pol
HIV Infections
D
G
R
C
L
View
15 28750025 L10L
PR
gag-pol
HIV Infections
D
G
R
C
L
View
16 28750025 L210W
RT
gag-pol
HIV Infections
D
G
R
C
L
View
17 28750025 M184V
RT
gag-pol
HIV Infections
D
G
R
C
L
View
18 28750025 M230LM
RT
gag-pol
HIV Infections
D
G
R
C
L
View
19 28750025 M41L
RT
gag-pol
HIV Infections
D
G
R
C
L
View
20 28750025 Q151M
RT
gag-pol
HIV Infections
D
G
R
C
L
View
21 28750025 Q151PQ
RT
gag-pol
HIV Infections
D
G
R
C
L
View
22 28750025 T215F
RT
gag-pol
HIV Infections
D
G
R
C
L
View
23 28750025 T215Y
RT
gag-pol
HIV Infections
D
G
R
C
L
View
24 28750025 T69N
RT
gag-pol
HIV Infections
D
G
R
C
L
View
25 28750025 T69T
RT
gag-pol
HIV Infections
D
G
R
C
L
View
26 28750025 V106E
RT
gag-pol
HIV Infections
D
G
R
C
L
View
27 28750025 V106I
RT
gag-pol
HIV Infections
D
G
R
C
L
View
28 28750025 V106K
RT
gag-pol
HIV Infections
D
G
R
C
L
View
29 28750025 V106V
RT
gag-pol
HIV Infections
D
G
R
C
L
View
30 28750025 V108A
RT
gag-pol
HIV Infections
D
G
R
C
L
View
31 28750025 V108I
RT
gag-pol
HIV Infections
D
G
R
C
L
View
32 28750025 V108IV
RT
gag-pol
HIV Infections
D
G
R
C
L
View
33 28750025 V118I
RT
gag-pol
HIV Infections
D
G
R
C
L
View
34 28750025 V179D
RT
gag-pol
HIV Infections
D
G
R
C
L
View
35 28750025 V179E
RT
gag-pol
HIV Infections
D
G
R
C
L
View
36 28750025 V179F
RT
gag-pol
HIV Infections
D
G
R
C
L
View
37 28750025 V82A
PR
gag-pol
HIV Infections
D
G
R
C
L
View
38 28750025 Y115C
RT
gag-pol
HIV Infections
D
G
R
C
L
View
39 28750025 Y115D
RT
gag-pol
HIV Infections
D
G
R
C
L
View
40 28750025 Y115G
RT
gag-pol
HIV Infections
D
G
R
C
L
View
41 28750025 Y115N
RT
gag-pol
HIV Infections
D
G
R
C
L
View
42 28750025 Y115Y
RT
gag-pol
HIV Infections
D
G
R
C
L
View
43 28750025 Y181C
RT
gag-pol
HIV Infections
D
G
R
C
L
View
44 28750025 Y181I
RT
gag-pol
HIV Infections
D
G
R
C
L
View
45 28750025 Y181V
RT
gag-pol
HIV Infections
D
G
R
C
L
View
46 28750025 Y188F
RT
gag-pol
HIV Infections
D
G
R
C
L
View
47 28750025 Y188L
RT
gag-pol
HIV Infections
D
G
R
C
L
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.